Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 03, 2025 15:28 ET | Source: NMDP

A Rockstar Puppet and a Life-Saving Message: NMDP Launches New Awareness Campaign to Help More Patients Receive Cell Therapy

NMDP launched a new PSA called "Know Your N-M-D-Ps,” featuring a puppet rock star, to raise awareness of blood stem cell transplants.
September 23, 2025 09:01 ET | Source: Smartphone Free Childhood US

Smartphone Free Childhood US Launches New Public Service Announcement: “Let’s Change The Norm”

KANSAS CITY, Mo., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Smartphone Free Childhood US (SFCxUS), a grassroots movement of parent advocates, today announced the release of its powerful new Public Service...
June 02, 2025 10:07 ET | Source: Spherix Global Insights

Access Barriers Hamper Early Line Adoption of UCB’s Bimzelx at Six Months Post-Launch in Psoriatic Arthritis and Axial Spondyloarthritis, According to Spherix Global Insights

EXTON, PA, June 02, 2025 (GLOBE NEWSWIRE) -- Just over six months into its dual launch across Psoriatic Arthritis (PsA) and Axial Spondyloarthritis (axSpA), UCB’s Bimzelx (bimekizumab) is...
April 29, 2025 09:00 ET | Source: YMCA of the USA

YMCA of the USA Urges Families to Participate in “Phones Down, Eyes Up™” This Summer

Launching during May’s National Water Safety Month, the YMCA's Phones Down Eyes Up campaign aims to reduce distractions and improve water safety awareness.
April 15, 2025 08:19 ET | Source: Biomerica, Inc.

Biomerica Reports Third Quarter Fiscal 2025 Financial Results

Q3 FY2025 Earnings Press Release
April 14, 2025 10:05 ET | Source: Spherix Global Insights

Johnson & Johnson’s Oral IL-23, Icotrokinra, Poised to Redefine the Psoriasis Treatment Landscape Following Positive Phase 3 Data, According to Spherix Global Insights

EXTON, PA, April 14, 2025 (GLOBE NEWSWIRE) -- Johnson & Johnson’s recent announcement of positive Phase 3 data for its oral IL-23 receptor antagonist, icotrokinra (JNJ-2113), has sparked notable...
March 27, 2025 15:38 ET | Source: Spherix Global Insights

US Rheumatologists Report Heightened Interest in Sotyktu for the Treatment of Psoriatic Arthritis Post Positive Trial Results, According to Spherix Global Insights

EXTON, PA, March 27, 2025 (GLOBE NEWSWIRE) -- In late 2024, Bristol Myers Squibb announced positive topline results from its pivotal Phase 3 trials, POETYK PsA-1 and PsA-2, evaluating Sotyktu...
February 13, 2025 11:55 ET | Source: Spherix Global Insights

Early Launch Metrics Indicate UCB’s Bimzelx (bimekizumab) Poised to Disrupt the U.S. Psoriatic Arthritis Market

EXTON, PA, Feb. 13, 2025 (GLOBE NEWSWIRE) -- UCB’s Bimzelx (bimekizumab) is making a strong entrance into the U.S. psoriatic arthritis (PsA) market, with early indicators suggesting it could drive a...
January 16, 2025 08:19 ET | Source: Biomerica, Inc.

United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® PSA Screening Test to Detect an Early Sign of Prostate Cancer

- 10-Minute PSA Test for Early Detection of Prostate Specific Antigen (PSA), an Early Warning Sign of Prostate Cancer - Prostate Cancer: The Second Most Common Cancer in Men Globally IRVINE, Calif.,...
September 04, 2024 08:19 ET | Source: Biomerica, Inc.

The Saudi Food and Drug Authority (SFDA) Approves Biomerica's At Home PSA Screening Test to Detect Early Signs of Prostate Cancer

- 10-Minute At-Home PSA Test for Early Detection of Prostate Cancer - First order already shipped to Saudi Arabia - Prostate Cancer is the Second Most Common Cancer in Men Globally ...